Ligand validation:8ZVX

PMS: phenylmethanesulfonic acid

PMS is a Ligand Of Interest in 8ZVX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8ZVX_PMS_B_301	61%	29%	0.131	0.919	1.06	1.74	1	2	0	0	100%	1
8ZVX_PMS_A_301	50%	17%	0.139	0.888	0.84	2.69	1	4	0	0	100%	1
8ZVS_PMS_A_302	68%	32%	0.118	0.929	0.73	1.92	-	2	0	0	100%	1
3W05_PMS_B_401	97%	34%	0.068	0.98	0.71	1.86	-	2	0	0	100%	1
2CBG_PMS_A_1225	93%	25%	0.094	0.989	1.54	1.51	2	2	2	0	100%	1
3RLI_PMS_A_400	93%	17%	0.081	0.975	1.44	2.16	1	4	0	0	100%	1
9EGA_PMS_B_702	91%	58%	0.095	0.98	0.35	1.23	-	1	3	0	100%	1
4Z9A_PMS_A_304	86%	36%	0.117	0.986	1.77	0.78	2	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.